Ledger.Open graph →
SEC Form D · filed July 12, 2024

Oisin Biotechnologies, Inc

Offering
$17.9M
Sold
$5.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Eric Garcia · Seattle, WAExecMatthew Scholz · Seattle, WAExec · DirectorJohn Lewis · Grand Cayman, Cayman IslandsExecDavid Gobel · Seattle, WADirectorStephen Hilbert · Seattle, WAExecJohn Lewis · Cayman Islands, Cayman IslandsExecGary Hudson · London, United KingdomExec · DirectorDanjuma Quarless · Seattle, WADirectorEric Garcia · San Francisco, CAExecMatthew Scholz · Seattle, WAExec · DirectorDavid Gobel · Seattle, WADirectorStephen Hilbert · Seattle, WAExecJohn Lewis · Edmonton, Alberta, CanadaExecGary Hudson · Seattle, WAExec · DirectorDanjuma Quarless · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗